Literature DB >> 12407372

Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections?

Juan P Umaña1, David T Lai, R Scott Mitchell, Kathleen A Moore, Filiberto Rodriguez, Robert C Robbins, Phillip E Oyer, Michael D Dake, Norman E Shumway, Bruce A Reitz, D Craig Miller.   

Abstract

OBJECTIVE: The optimal treatment of patients with acute type B dissections continues to be debated.
METHODS: A 36-year clinical experience of medical and surgical treatments in 189 patients was retrospectively analyzed (multivariable Cox proportional hazards model) with respect to three outcome end points: all deaths, freedom from reoperation, and freedom from late aortic complications or death. Propensity score analysis identified 2 quintiles (quintiles I and II, consisting of 142 comparable patients) for further comparison of the effects of surgical versus medical treatment.
RESULTS: Shock (hazard ratio 14.5, 95% confidence interval 4.7-44.5, P <.001) and visceral ischemia (hazard ratio 10.9, 95% confidence interval 3.9-30.3, P <.001) largely predominated as determinants of death, along with 6 other risk factors (arch involvement, rupture, stroke, previous sternotomy, and coronary or lung disease), which roughly doubled the hazard of death. Female sex was a significant but weaker predictor of death. Renal dysfunction, year of presentation, age, and mode of therapy (medical vs surgical) had no important bearing on overall survival. The actuarial survival estimates for all patients were 71%, 60%, 35%, and 17% at 1, 5, 10, and 15 years, respectively, and were similar for the medical and surgical patients. Reoperation and late aortic complications were predicted by the presence of Marfan syndrome. For the propensity-matched patients in quintiles I and II, survival, freedom from reoperation, and freedom from aortic complications were almost identical in the medically treated and surgical subsets.
CONCLUSIONS: The prognosis for patients with acute type B aortic dissection is bleak and determined primarily by dissection-related and patient-specific risk factors, which do not appear to be readily modifiable.

Entities:  

Mesh:

Year:  2002        PMID: 12407372     DOI: 10.1067/mtc.2002.123131

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  24 in total

Review 1.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

Review 2.  Diagnosis and management of patients with aortic dissection.

Authors:  Hüseyin Ince; Christoph A Nienaber
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

3.  Best surgical option for arch extension of type B aortic dissection: the open approach.

Authors:  Joon Bum Kim; Thoralf M Sundt
Journal:  Ann Cardiothorac Surg       Date:  2014-07

Review 4.  [Malperfusion in aortic dissection: diagnostic problems and therapeutic procedures].

Authors:  R A Jánosi; D Böse; T Konorza; H Eggebrecht; K Tsagakis; H Jakob; R Erbel
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

Review 5.  Current strategy of endovascular aortic repair for thoracic aortic aneurysms.

Authors:  Toru Kuratani; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-08-12

6.  Predicting aortic enlargement in type B aortic dissection.

Authors:  Santi Trimarchi; Frederik H W Jonker; Guido H W van Bogerijen; Jip L Tolenaar; Frans L Moll; Martin Czerny; Himanshu J Patel
Journal:  Ann Cardiothorac Surg       Date:  2014-05

7.  Cardiac Arrest Due to Dynamic Obstruction of Aorta during Course of the Acute Type B Aortic Dissection.

Authors:  Kimimasa Sakata; Akio Yamashita; Katsunori Takeuchi; Tatsuro Matsuo; Masaya Aoki; Naoki Yoshimura
Journal:  Ann Vasc Dis       Date:  2015-10-02

8.  Thrombocytopenia: an early marker of late mortality in type B aortic dissection.

Authors:  Pascal Delsart; Jean-Paul Beregi; Patrick Devos; Stephan Haulon; Marco Midulla; Claire Mounier-Vehier
Journal:  Heart Vessels       Date:  2013-04-19       Impact factor: 2.037

Review 9.  Type B Aortic Dissection: A Review of Prognostic Factors and Meta-analysis of Treatment Options.

Authors:  Thomas Luebke; Jan Brunkwall
Journal:  Aorta (Stamford)       Date:  2014-12-01

10.  Standard of practice for the endovascular treatment of thoracic aortic aneurysms and type B dissections.

Authors:  Fabrizio Fanelli; Michael D Dake
Journal:  Cardiovasc Intervent Radiol       Date:  2009-08-18       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.